| abstract |
Disclosed are an immune checkpoint inhibitor capable of blocking a PD-1/PD-L1 signaling pathway, a phenyl-substituted five-membered heterocyclic compound or a pharmaceutically acceptable salt, racemate, optical isomer or solvent compound thereof, a preparation method therefor, use thereof, and a pharmaceutical composition comprising same. Such compound is represented by formula I below. |